BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 23911420)

  • 1. IVIG immunotherapy protects against synaptic dysfunction in Alzheimer's disease through complement anaphylatoxin C5a-mediated AMPA-CREB-C/EBP signaling pathway.
    Gong B; Pan Y; Zhao W; Knable L; Vempati P; Begum S; Ho L; Wang J; Yemul S; Barnum S; Bilski A; Gong BY; Pasinetti GM
    Mol Immunol; 2013 Dec; 56(4):619-29. PubMed ID: 23911420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
    Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of complement systems in IVIG mediated attenuation of cognitive deterioration in Alzheimer's disease.
    Gong B; Levine S; Barnum SR; Pasinetti GM
    Curr Alzheimer Res; 2014; 11(7):637-44. PubMed ID: 25115545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment.
    Gong B; Vitolo OV; Trinchese F; Liu S; Shelanski M; Arancio O
    J Clin Invest; 2004 Dec; 114(11):1624-34. PubMed ID: 15578094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease.
    Gao L; Tian M; Zhao HY; Xu QQ; Huang YM; Si QC; Tian Q; Wu QM; Hu XM; Sun LB; McClintock SM; Zeng Y
    J Neurochem; 2016 Feb; 136(3):620-36. PubMed ID: 26577931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Asarone inhibits neuronal apoptosis via the CaMKII/CREB/Bcl-2 signaling pathway in an in vitro model and AβPP/PS1 mice.
    Wei G; Chen YB; Chen DF; Lai XP; Liu DH; Deng RD; Zhou JH; Zhang SX; Li YW; Lii H; Liu LF; Wang Q; Nie H
    J Alzheimers Dis; 2013; 33(3):863-80. PubMed ID: 23064259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer's disease.
    Simón AM; de Maturana RL; Ricobaraza A; Escribano L; Schiapparelli L; Cuadrado-Tejedor M; Pérez-Mediavilla A; Avila J; Del Río J; Frechilla D
    J Alzheimers Dis; 2009; 17(4):773-86. PubMed ID: 19542617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CREB-regulated transcription coactivator 1-dependent transcription in Alzheimer's disease mice.
    Saura CA
    Neurodegener Dis; 2012; 10(1-4):250-2. PubMed ID: 22236576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Sierksma AS; Rutten K; Sydlik S; Rostamian S; Steinbusch HW; van den Hove DL; Prickaerts J
    Neuropharmacology; 2013 Jan; 64():124-36. PubMed ID: 22771768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease.
    Landlinger C; Oberleitner L; Gruber P; Noiges B; Yatsyk K; Santic R; Mandler M; Staffler G
    J Neuroinflammation; 2015 Aug; 12():150. PubMed ID: 26275910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
    Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
    Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptors for the anaphylatoxin C5a (CD88) on human mesangial cells.
    Wilmer WA; Kaumaya PT; Ember JA; Cosio FG
    J Immunol; 1998 Jun; 160(11):5646-52. PubMed ID: 9605171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
    Devi L; Ohno M
    Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3',5'-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: studies with a galanin receptor 2 agonist and galanin receptor 1 knockout mice.
    Badie-Mahdavi H; Lu X; Behrens MM; Bartfai T
    Neuroscience; 2005; 133(2):591-604. PubMed ID: 15885916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice.
    Zeitlin R; Patel S; Burgess S; Arendash GW; Echeverria V
    Brain Res; 2011 Oct; 1417():127-36. PubMed ID: 21907331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CREB is necessary for synaptic maintenance and learning-induced changes of the AMPA receptor GluA1 subunit.
    Middei S; Houeland G; Cavallucci V; Ammassari-Teule M; D'Amelio M; Marie H
    Hippocampus; 2013 Jun; 23(6):488-99. PubMed ID: 23504989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of S14G-humanin against beta-amyloid induced LTP inhibition in mouse hippocampal slices.
    Zhang W; Miao J; Hao J; Li Z; Xu J; Liu R; Cao F; Wang R; Chen J; Li Z
    Peptides; 2009 Jun; 30(6):1197-202. PubMed ID: 19463756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
    Rakover I; Arbel M; Solomon B
    Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.